Ledger.Open graph →
SEC Form D · filed September 25, 2018

Armis Biopharma, Inc

Offering
$10.0M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
FORT COLLINS, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Dev Equity Partners II, LLC · Tucson, AZDirectorPeter E. Mogk · DETROIT, MIExec · DirectorCameron Gray · CAMBRIDGE, MADirectorAnanth Pradeep · El Cerrito, CAExec · DirectorRohan N. Oza · New York, NYDirectorMatthew Chick · St. Peter Port, Y7DirectorTimothy W. Reick · New York, NYDirectorDominick Maggio · New York, NYExecDavid Depaolo · New York, NYDirectorStephen L. Scott · San Diego, CAExecDaniel Passeri · CAMBRIDGE, MADirectorDon T. Ebanks · Grand Cayman, Cayman IslandsExec · DirectorClayton N. Christopher · New York, NYExec · DirectorGang Lu · Laguna Hills, CADirectorMaiden Lane Spin-Off Advisors, LLC · New York, NYDirectorThomas Deutsch · New York, NYDirectorStephen Coder · Fort Collins, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗